Steven W. Brostoff - Carlsbad CA Darcy B. Wilson - La Jolla CA Lawrence R. Smith - Cardiff CA Daniel P. Gold - Del Mar CA Dennis J. Carlo - Rancho Santa Fe CA
The present invention provides vaccines and a means of vaccinating a mammal so as to prevent or control specific T cell mediated pathologies or to treat the unregulated replication of T cells. The vaccine is composed of a T cell receptor (TCR) or a fragment thereof corresponding to a TCR present on the surface of T cells mediating the pathology. The vaccine fragment can be a peptide corresponding to sequences of TCRs characteristic of the T cells mediating said pathology. The vaccine is administered to the mammal in a manner that induces an immunologically effective response so as to affect the course of the disease. The invention additionally provides specific -chain variable regions of the T cell receptor, designated V6. 2/3, V6. 5, V2, V5. 1, V13 and V7, which are central to the pathogenesis of multiple sclerosis (MS).
Darcy B. Wilson - La Jolla CA Donald E. Mosier - Del Mar CA
Assignee:
Lidak Pharmaceuticals - La Jolla CA
International Classification:
A61K 3500 A61K 4800 C12N 1500
US Classification:
800 2
Abstract:
Laboratory non-human animals in which the immune system of a donor is induced in and thrives in vivo and expresses the immune response of the donor animal in a recipient non-human animal of a different species than the donor, and wherein malignant immune system cells of the donor can be induced in the recipient non-human animal by injection of non-malignant donor into the recipient are disclosed.
Darcy B. Wilson - La Jolla CA Donald E. Mosier - Del Mar CA
Assignee:
Lidak Pharmaceuticals - La Jolla CA
International Classification:
A61K 3500
US Classification:
800 2
Abstract:
Laboratory non-human animals in which the immune system of a human donor is induced in and thrives in vivo and expresses the immune response of the human donor in a recipient non-human animal, and wherein malignant immune system cells of the human donor can be induced in the recipient non-human animal by injection of non-malignant donor cells into the recipient are disclosed.